Letson Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.9M Sell
110,947
-361
-0.3% -$77.7K 10.24% 1
2026
Q1
$24.2M Buy
111,308
+15
+0% +$3.33K 9.3% 1
2025
Q4
$25.4M Sell
111,293
-36
-0% -$8.2K 9.32% 1
2025
Q3
$25.8M Buy
111,329
+324
+0.3% +$66K 9.25% 1
2025
Q2
$20.6M Sell
111,005
-520
-0.5% -$96.6K 8.14% 1
2025
Q1
$23.4M Sell
111,525
-29
-0% -$5.64K 9.42% 1
2024
Q4
$19.8M Sell
111,554
-122
-0.1% -$22.4K 8.01% 1
2024
Q3
$22.1M Buy
111,676
+205
+0.2% +$38.3K 8.66% 1
2024
Q2
$19.1M Sell
111,471
-37
-0% -$6.13K 8.46% 1
2024
Q1
$20.3M Buy
111,508
+1,635
+1% +$282K 8.59% 1
2023
Q4
$17M Buy
+109,873
New +$16M 7.91% 1

Other funds holding ABBV

Letson Investment Management's ABBV Position: Q2 2026 in Review

Letson Investment Management reduced its AbbVie (ABBV) stake by 0.32% in Q2 2026, selling an estimated $77.7K and leaving 110,947 shares worth $27.9M. The position accounts for 10.24% of the portfolio, ranked #1.

Letson Investment Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Letson Investment Management held 110,947 shares of AbbVie worth $27.9M as of Q2 2026.
  • Letson Investment Management sold 361 AbbVie shares in Q2 2026, an estimated $77.7K.
  • AbbVie made up 10.24% of Letson Investment Management's portfolio in Q2 2026, its #1 holding.
  • Letson Investment Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Letson Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.